Unusual movement in US stocks | Medtronic (MDT.US) rises over 4% as Q1 FY2026 results exceed expectations and full-year profit guidance is increased.

According to the Wise Finance APP, on Wednesday, Medtronic (MDT.US) rose more than 4%, closing at $94.04. The financial report shows that Medtronic's revenue for the first quarter of fiscal year 2026 was $8.6 billion, surpassing market expectations of $8.4 billion. This was mainly driven by growth in the cardiovascular products division, with revenue from its heart ablation products increasing by nearly 50%. Adjusted earnings per share increased by 2% to $1.26, higher than market expectations of $1.23.